More about

University Of California San Francisco

News
May 26, 2022
6 min read
Save

CAR-T for multiple myeloma: earlier treatment, new targets and ‘patient-friendly’ care

CAR-T for multiple myeloma: earlier treatment, new targets and ‘patient-friendly’ care

Although chimeric antigen receptor T-cell therapy is approved for treatment of multiple myeloma, commercially available products are limited to patients who received at least four prior lines of therapy.

News
May 25, 2022
3 min read
Save

Transcatheter pulmonary valve replacement confers favorable 1-year outcomes, 100% survival

Transcatheter pulmonary valve replacement confers favorable 1-year outcomes, 100% survival

ATLANTA — A speaker reported 100% 1-year survival and high freedom from pulmonary regurgitation, stenosis and reintervention in patients who underwent transcatheter pulmonary valve replacement.

News
May 15, 2022
3 min read
Save

Participation in cardiac rehabilitation after AVR varies greatly across hospitals

Participation in cardiac rehabilitation after AVR varies greatly across hospitals

Participation in cardiac rehabilitation following surgical or transcatheter aortic valve replacement varies greatly from hospital to hospital, although researchers observed a correlation between participation and treatment strategy.

News
April 28, 2022
2 min read
Save

Virtual, hybrid cardiac rehabilitation programs yield benefits similar to in-person

Virtual, hybrid cardiac rehabilitation programs yield benefits similar to in-person

Patients referred for cardiac rehabilitation sessions experienced similar improvements in clinical outcomes whether the program was in-person, hybrid or virtual, including similar changes in 6-minute walk distance, researchers reported.

News
April 28, 2022
1 min read
Save

Fewer menopause symptoms, HT prescriptions among Black and Hispanic vs. white veterans

Fewer menopause symptoms, HT prescriptions among Black and Hispanic vs. white veterans

Reported menopause symptoms and prescriptions for hormone therapy were less common among Black and Hispanic female veterans, highlighting disparities in the discussion, documentation and management of menopause, according to researchers.

News
April 25, 2022
2 min read
Save

Diabetes overtreatment common in nursing homes, with little medication deintensification

Diabetes overtreatment common in nursing homes, with little medication deintensification

Type 2 diabetes overtreatment among nursing home residents is common, with few residents having their medication regimens appropriately deintensified, according to results published in the Journal of the American Geriatric Society.

News
April 20, 2022
15 min watch
Save

VIDEO: Hidradenitis suppurativa patient experience, management, care ‘key themes’ at meeting

VIDEO: Hidradenitis suppurativa patient experience, management, care ‘key themes’ at meeting

In this video, Haley Naik, MD, discusses “three key themes” from the hidradenitis suppurativa symposiums at the American Academy of Dermatology Annual Meeting.

News
April 19, 2022
1 min watch
Save

VIDEO: Dedicated hidradenitis suppurativa session ‘practical’ addition to AAD meeting

VIDEO: Dedicated hidradenitis suppurativa session ‘practical’ addition to AAD meeting

In this video, Haley Naik, MD, highlights the surgical management of hidradenitis suppurativa session at the American Academy of Dermatology Annual Meeting.

News
April 19, 2022
1 min watch
Save

VIDEO: Expert highlights patient-led session during hidradenitis suppurativa symposium

VIDEO: Expert highlights patient-led session during hidradenitis suppurativa symposium

In this video, Haley Naik, MD, spoke with Healio about a patient-led presentation on hidradenitis suppurativa at the American Academy of Dermatology Annual Meeting.

News
April 14, 2022
3 min read
Save

UCSF researchers hope to cure sickle cell disease through CRISPR gene editing

UCSF researchers hope to cure sickle cell disease through CRISPR gene editing

With the aid of $17 million in grant funding, UCSF Benioff Children’s Hospital Oakland will initiate a 4-year trial evaluating CRISPR/Cas9 gene editing as a potential cure for sickle cell disease.

View more